Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CAMPION: Tianeptine vs Escitalopram in MDD
NCT01309776Phase 4Completed
- Sponsor
- Samsung Medical Center
- Start
- Mar 2011
- Primary completion
- Sep 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of tianeptine in major depressive disorder (MDD), sponsored by Samsung Medical Center. Primary endpoint: Hamilton Rating Scale for Depression at 12 weeks. Started Mar 2011; status: completed.
02
Drugs
tianeptine
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT01309776.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01309776.